Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea
Main Authors: | Chin, Sang Ouk, Chung, Choon Hee, Chung, Yoon-Sok, Kim, Byung-Joon, Kim, Hee Young, Kim, In-Ju, Kim, Jung Guk, Kim, Min-Seon, Kim, Seong-Yeon, Lee, Eun Jig, Lee, Ki Young, Kim, Sung-Woon |
---|---|
Format: | Online |
Language: | English |
Published: |
BMJ Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466761/ |
Similar Items
-
Acromegaly Quality of Life Questionnaire (AcroQoL)
by: Badia, Xavier, et al.
Published: (2004) -
Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly
by: Tutuncu, Yasemin, et al.
Published: (2011) -
Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study
by: Neggers, Sebastian JCMM, et al.
Published: (2015) -
A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly
by: Mercado, Moises, et al.
Published: (2007) -
Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers
by: Tiberg, Fredrik, et al.
Published: (2015)